As noted above, B-lymphoblastic leukemia/lymphoma with BCR::ABL1 fusion often exhibits aberrant expression of myeloid antigens CD13 and CD33, although these findings are not specific for this subtype (see below). Here, CD33 is linked to lymphoma.